About
Shin Nippon Biomedical Laboratories (SNBL), was founded in Kagoshima as Japan’s first contract research organization in 1957. Since then, SNBL has steadily expanded and innovated to become a global business that works in the pre-clinical research, clinical pharmacology research, pharmacokinetics and analysis, clinical trial, SMO, and other industries. In recent years, they have built strong partnerships based on their corporate philosophy, including with their translational research business partner. SNBL is striving toward globalization and expanded from Japan into North America, Europe, and other parts of Asia. SNBL has over 50 years of experience as a contract research organization. They provide study data about safety and efficacy pharmaceuticals, which is essential to pharmaceutical companies in the drug development process. In addition to their abundant experience, they have established a global group with branches in Japan, the United States, China, Cambodia, and other globa
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 2,068 investors are based in Tokyo, Tokyo, Japan.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Tokyo, Japan
Contact Information
Find more investors like Shin
Search Investors